Yen Weakness Persists Amid Global Risk-On Sentiment and FDA News
The Japanese yen continues to underperform against major currencies, with USD/JPY holding above 149.00 as risk-on sentiment dominates global markets. The yen's weakness is attributed to widening interest rate differentials and the Bank of Japan's commitment to maintaining accommodative policy despite global tightening trends. Novo Nordisk's anticipated FDA approval for high-dose Wegovy has boosted risk appetite in equity markets, indirectly supporting higher-yielding currencies against the yen. The US dollar's push for critical minerals independence adds another layer of support for USD strength. Technical indicators show USD/JPY targeting the 150.00 resistance level, while EUR/JPY trades near 162.50. Traders are monitoring Japanese economic data for any signs of policy shift pressures. The combination of global risk-on sentiment and Japan's policy divergence suggests continued yen weakness in the near term.
Related Symbols:
USDJPY
EURJPY
This is a summary of the original article by thestockmarketwatch.com. To read the complete article, please visit the source website:
Read Full Article at thestockmarketwatch.comNews data provided by Marketaux. ForexSentiment.live provides this summary as a convenience with proper attribution to the original source. The full article is available at the original publisher's website.
